A startup developing artificial red blood cells coated with a lipid bilayer. These cells possess oxygen-carrying capacity equivalent to red blood cells and enable long-term storage, aiming to revolutionize transfusion medicine through stable blood transfusions in veterinary medicine and future practical application in human healthcare.
A biotech startup developing T-cell and NK-cell therapies derived from low-immunogenicity iPS cells. It aims to provide new treatments for solid tumors and autoimmune diseases, contributing to the treatment of previously difficult-to-treat intractable diseases.
The University of Osaka–developed “next-generation microfluidic PCR technology” is leveraged to deliver a rapid and easy-to-use gut microbiome testing service, and to operate a community platform business that connects people with digestive concerns with companies offering products to support gut health. We also provide contract testing services for gut microbiome analysis.
It is well established that drivers’ spatial cognitive abilities are closely linked to traffic accident risk. Our company is committed to advancing driver safety and extending driver retirement age by leveraging proprietary technologies that enable the quantitative assessment and targeted training of spatial cognition ability.
Business Utilizing Odor Quantification Technology Based on Olfactory Receptor Responses